ArticleExploration of targeted anti-tumor therapy2026
Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model.
Tauana Christina Dias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.